Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Assessing the dynamics of heterosexual genital bacteria transmission and the impact of sex on microbiome composition and inflammation in the female and male genital tracts in South-central Uganda

EF 2024-25

Résumé
Supervisor: Dr. Rupert Kaul, University of Toronto Human immunodeficiency virus (HIV) transmission rates are disproportionately high among African, Caribbean, and other Black (ACB) individuals in Sub-Saharan Africa. High HIV risk may be linked to an imbalance of bacteria in the genital tract. Bacterial vaginosis (BV), a clinical condition characterized by an overgrowth of "harmful" bacterial species instead of "healthy" Lactobacillus species in the vagina, increases HIV risk by 60% by causing vaginal inflammation. While standard antibiotic BV treatment reduces vaginal inflammation by clearing harmful bacteria, its impact on heterosexual HIV transmission is unknown. We have recently found that penile-vaginal sex induces a 48-72h window of genital inflammation in Toronto couples, which coincides with the timing of HIV infection. While the exchange of genital bacteria during condomless sex contributes to inflammation, how the genital tract counteracts it is poorly understood. Our clinical study tests a novel treatment strategy to reduce the inflammation induced by sex amongst heterosexual couples in Uganda, where HIV and BV rates are high. By providing BV treatment to female partners before sex, we expect to clear harmful bacteria, reduce vaginal inflammation, and lower female HIV risk. BV treatment may also reduce the transfer of harmful vaginal bacteria to the penis during sex, thereby reducing male HIV risk. Additionally, we will assess other immunological components in the vagina to evaluate how they protect against inflammation after sex. The accessibility of HIV medications falls short of target goals, especially for ACB individuals globally, emphasizing the need for better prevention strategies. This study aims to offer alternative clinical interventions to reduce HIV risk and address the stigma surrounding it. Findings will be shared with local Toronto HIV clinics, international HIV conferences, and communities in Uganda to advance HIV prevention efforts.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
517106
Name
Tsang Tsz Sin
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Assessing the dynamics of heterosexual genital bacteria transmission and the impact of sex on microbiome composition and inflammation in the female and male genital tracts in South-central Uganda
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Antibiotics; Bacterial Vaginosis; Genital Microbiome; Hiv Transmission And Acquisition; Immunoglobulins And Antibodies; Immunology; Inflammatory Cytokines; Penile-Vaginal Sex; Qpcr And Rna Sequencing; Translational Research
Abstract
Supervisor: Dr. Rupert Kaul, University of Toronto Human immunodeficiency virus (HIV) transmission rates are disproportionately high among African, Caribbean, and other Black (ACB) individuals in Sub-Saharan Africa. High HIV risk may be linked to an imbalance of bacteria in the genital tract. Bacterial vaginosis (BV), a clinical condition characterized by an overgrowth of "harmful" bacterial species instead of "healthy" Lactobacillus species in the vagina, increases HIV risk by 60% by causing vaginal inflammation. While standard antibiotic BV treatment reduces vaginal inflammation by clearing harmful bacteria, its impact on heterosexual HIV transmission is unknown. We have recently found that penile-vaginal sex induces a 48-72h window of genital inflammation in Toronto couples, which coincides with the timing of HIV infection. While the exchange of genital bacteria during condomless sex contributes to inflammation, how the genital tract counteracts it is poorly understood. Our clinical study tests a novel treatment strategy to reduce the inflammation induced by sex amongst heterosexual couples in Uganda, where HIV and BV rates are high. By providing BV treatment to female partners before sex, we expect to clear harmful bacteria, reduce vaginal inflammation, and lower female HIV risk. BV treatment may also reduce the transfer of harmful vaginal bacteria to the penis during sex, thereby reducing male HIV risk. Additionally, we will assess other immunological components in the vagina to evaluate how they protect against inflammation after sex. The accessibility of HIV medications falls short of target goals, especially for ACB individuals globally, emphasizing the need for better prevention strategies. This study aims to offer alternative clinical interventions to reduce HIV risk and address the stigma surrounding it. Findings will be shared with local Toronto HIV clinics, international HIV conferences, and communities in Uganda to advance HIV prevention efforts.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tsang, Tsz Sin
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~